anti-CEA antibody (Antisoma)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-CEA antibody (Antisoma)
Drug Alias NamePR1A3-based product (Antisoma)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 antagonists
TargetsCarcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsColorectal NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe UK Imperial Cancer Research Fund
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAntisoma
Active IndicationsN/A
Inactive IndicationsColorectal NeoplasmsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A